EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 106 filers reported holding EPIZYME INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,118,000 | -23.6% | 82,496 | 0.0% | 0.01% | -26.7% |
| Q1 2018 | $1,464,000 | +32.8% | 82,496 | -6.0% | 0.02% | +50.0% |
| Q4 2017 | $1,102,000 | -37.6% | 87,802 | -5.3% | 0.01% | -28.6% |
| Q3 2017 | $1,765,000 | +23.7% | 92,668 | -2.0% | 0.01% | +16.7% |
| Q2 2017 | $1,427,000 | -12.0% | 94,526 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $1,621,000 | +41.7% | 94,526 | 0.0% | 0.01% | +55.6% |
| Q4 2016 | $1,144,000 | +23.0% | 94,526 | 0.0% | 0.01% | +28.6% |
| Q3 2016 | $930,000 | -3.9% | 94,526 | 0.0% | 0.01% | -12.5% |
| Q2 2016 | $968,000 | -15.5% | 94,526 | 0.0% | 0.01% | -27.3% |
| Q1 2016 | $1,146,000 | -24.3% | 94,526 | 0.0% | 0.01% | -26.7% |
| Q4 2015 | $1,514,000 | +24.5% | 94,526 | 0.0% | 0.02% | +15.4% |
| Q3 2015 | $1,216,000 | -46.4% | 94,526 | 0.0% | 0.01% | -53.6% |
| Q2 2015 | $2,269,000 | +27.8% | 94,526 | 0.0% | 0.03% | +40.0% |
| Q1 2015 | $1,776,000 | -0.4% | 94,526 | 0.0% | 0.02% | -4.8% |
| Q4 2014 | $1,784,000 | – | 94,526 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |